Expert Answer
Do statins raise Lp(a), and is that dangerous?
Quick Answer
Statins lower LDL and ApoB but may modestly raise Lp(a) in some people, because Lp(a) is set mostly by how much your body produces rather than how fast it clears — and statins work by speeding clearance. In Attia's Lp(a) episode with researcher Benoit Arsenault, the takeaway is that the overall drop in atherogenic particles still generally lowers cardiovascular risk, so a rise in Lp(a) alone is not a reason to stop a prescribed statin. Any medication change is a physician decision.
Strong Consensus
on ApoB overall
What Researchers Say
In his dedicated Lp(a) episode with researcher Benoit Arsenault, explains that statins raise the liver's LDL clearance, but Lp(a) is driven by production, so statins do not lower it and can nudge it up — while still cutting overall ApoB-particle risk, so the net effect is generally protective.
Argues for measuring Lp(a) as part of advanced lipid testing, since a standard panel misses it — relevant because Lp(a) behaves differently from the LDL that statins target.
No direct statin-and-Lp(a) coverage in the analyzed videos.
No direct statin-and-Lp(a) coverage in the analyzed videos.
No direct statin-and-Lp(a) coverage in the analyzed videos.
Detailed Answer
It sounds like a contradiction: a drug meant to protect your heart can nudge one heart-risk marker upward. The resolution is that Lp(a) is not built like the cholesterol statins are designed to lower. Statins work largely by increasing the liver's clearance of LDL particles. Lp(a), by contrast, is determined mostly by how much your body produces, not by how quickly it is cleared — so a clearance-boosting drug does little to lower it, and in some people the level ticks up.
That does not mean the statin is failing. In Attia's Lp(a) episode with lipoprotein researcher Benoit Arsenault, the framing is that what matters for cardiovascular risk is the total burden of atherogenic (ApoB-containing) particles. A statin can meaningfully reduce that overall burden even if Lp(a) itself does not fall — so for many patients with high Lp(a), the medication is still net-beneficial. This is a good example of why single-marker thinking breaks down: one number moving the "wrong" way does not overturn the direction of overall risk.
The hard guardrail: this is not a reason to start or stop any medication on your own. If your Lp(a) rose after starting a statin, that is a conversation to have with your doctor, not a signal to quit. Lp(a) also does not respond much to diet or the lifestyle changes that lower LDL, which is part of why it is discussed as a distinct, largely genetic risk factor. This page is educational synthesis of what these experts said on video, not medical advice.
Related Questions
Why do statins raise Lp(a) instead of lowering it?
Because Lp(a) is driven mostly by production, not clearance. Statins lower LDL by boosting the liver's clearance of particles, which does little for Lp(a) and can slightly raise it in some people, per Attia's Lp(a) episode.
Should I stop my statin if my Lp(a) went up?
No — that is a decision for your physician, not a self-directed change. The experts' point is that a statin can still reduce your overall atherogenic particle burden and cardiovascular risk even if Lp(a) itself does not fall.
Does anything lower Lp(a)?
Lp(a) does not respond much to the diet and lifestyle changes that lower LDL, which is why it is treated as a distinct, largely genetic marker. Options for managing it are an evolving, physician-guided area.
Is a higher Lp(a) on a statin a sign the drug isn't working?
Not necessarily. Statins mainly act on LDL and ApoB, not Lp(a). Judging a statin only by Lp(a) can be misleading — the broader particle burden is what the experts weigh.
More Questions About ApoB
Get the exact protocol for ApoB
This page covers what researchers agree on. Pro gives you the specific dosages, timing schedules, and interaction warnings they each recommend — with video citations you can verify.
- Expert-by-expert breakdowns on any topic
- Chat with 1000+ hours of research data
- Video citations with timestamps you can check
Cancel anytime
Full ApoB Consensus Report
See what all the experts agree and disagree on